136 related articles for article (PubMed ID: 16783844)
41. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
[TBL] [Abstract][Full Text] [Related]
42. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
Timmer-Bonte JN; Tjan-Heijnen VC
Anticancer Drugs; 2006 Sep; 17(8):881-9. PubMed ID: 16940798
[TBL] [Abstract][Full Text] [Related]
43. Antibacterial prophylaxis in neutropenic patients.
Viscoli C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S60-5. PubMed ID: 17706926
[TBL] [Abstract][Full Text] [Related]
44. [Prognostic factors for febrile neutropenia].
Ray-Coquard I; Borg C; Bachelot T; Fayette J; Zufferey L; Guastalla JP; Ghesquière H; Blay JY; Sebban C; Marec-Bérard P; Biron P
Bull Cancer; 2006 May; 93(5):501-6. PubMed ID: 16777629
[TBL] [Abstract][Full Text] [Related]
45. Antibiotic prophylaxia in patients with severe acute pancreatitis.
Zhou YM; Xue ZL; Li YM; Zhu YQ; Cao N
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):23-7. PubMed ID: 15730913
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis.
Kouranos V; Dimopoulos G; Vassias A; Syrigos KN
Cancer Lett; 2011 Dec; 313(1):9-14. PubMed ID: 21955615
[TBL] [Abstract][Full Text] [Related]
47. Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics.
Wingard JR; Elmongy M
Crit Rev Oncol Hematol; 2009 Nov; 72(2):144-54. PubMed ID: 19237297
[TBL] [Abstract][Full Text] [Related]
48. Antibiotics for the prevention of febrile neutropenia.
Pascoe J; Steven N
Curr Opin Hematol; 2009 Jan; 16(1):48-52. PubMed ID: 19057204
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic approach to a patient with febrile neutropenia].
Duraković N; Nemet D
Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
[TBL] [Abstract][Full Text] [Related]
50. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
Mullen CA
Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
[TBL] [Abstract][Full Text] [Related]
51. Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
Wingard JR; Eldjerou L; Leather H
Curr Opin Hematol; 2012 Jan; 19(1):21-6. PubMed ID: 22080847
[TBL] [Abstract][Full Text] [Related]
52. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
53. Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.
Saloustros E; Tryfonidis K; Georgoulias V
Expert Opin Pharmacother; 2011 Apr; 12(6):851-63. PubMed ID: 21254862
[TBL] [Abstract][Full Text] [Related]
54. [Antibiotic therapy in leukopenia].
Böhme A; Shah PM; Stille W; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1120-5. PubMed ID: 9782739
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.
Crawford J; Dale DC; Lyman GH
Cancer; 2004 Jan; 100(2):228-37. PubMed ID: 14716755
[TBL] [Abstract][Full Text] [Related]
56. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice?
Calitri C; Ruberto E; Castagnola E
Eur J Haematol; 2018 Dec; 101(6):721-727. PubMed ID: 30107054
[TBL] [Abstract][Full Text] [Related]
57. Antibiotic prophylaxis in acute necrotizing pancreatitis revisited.
Segarra-Newnham M; Hough A
Ann Pharmacother; 2009 Sep; 43(9):1486-95. PubMed ID: 19690227
[TBL] [Abstract][Full Text] [Related]
58. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
59. [Prevention and therapy of infections in tumor patients].
Burgmann H
Wien Med Wochenschr; 2001; 151(24):600-14. PubMed ID: 11820177
[TBL] [Abstract][Full Text] [Related]
60. Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy.
Daniel DB; Crawford J;
Curr Hematol Rep; 2005 Nov; 4(6):441-5. PubMed ID: 16232380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]